BSA
DVA icon

Braun Stacey Associates’s DaVita DVA Stock Holding History

Braun Stacey Associates’s Portfolio DVA Stock Details DVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,700
Closed -$374K – 180
2015
Q2 		$374K Buy
+4,700
New +$386K 0.02% 249

Other funds holding DVA

Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.65% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Braun Stacey Associates's DVA Position: Q3 2015 in Review

Braun Stacey Associates sold out of DaVita (DVA) in Q3 2015, closing a stake of 4,700 shares — an estimated $374K sold.

Braun Stacey Associates first reported a position in DVA in Q2 2015 and held it in 1 quarter. The position peaked at $374K in Q2 2015. 471 funds tracked by Wall St. Rank hold DVA as of Q3 2015.

  • Braun Stacey Associates reported no remaining DaVita position as of Q3 2015 after selling out during the quarter.
  • Braun Stacey Associates sold 4,700 DaVita shares in Q3 2015, an estimated $374K.
  • Braun Stacey Associates first reported a position in DaVita in Q2 2015 and held it in 1 quarter.
  • Braun Stacey Associates's DaVita position peaked at $374K in Q2 2015.
  • 471 funds tracked by Wall St. Rank held DaVita as of Q3 2015.

Based on Braun Stacey Associates's 13F filing for Q3 2015, filed 1 Dec 2015.